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Patient perspective of systemic lupus erythematosus in relation
to health-related quality of life concepts: a qualitative study
K McElhone1, J Abbott2, J Gray3, A Williams4 and L-S Teh1
1Department of Rheumatology, Royal Blackburn Hospital, Blackburn, UK; 2Faculty of Health and Social Care
University of Central Lancashire, Preston, UK; 3Clinical Trials Department, Wrightington Hospital, Wigan, UK;
and 4Department of Health Care Professions, University of Salford, Salford, UK
We sought to understand the patients’ ‘lived experiences of systemic lupus erythematosus
(SLE)’ by exploring, describing and clarifying the patients’ perspective of how they felt
about having SLE and how the disease impacted on their lives, both positively and/or nega-
tively. An interpretative phenomenological approach was employed. Semi-structured inter-
views were undertaken with 30 females with SLE across a wide range of age (21 to 75 years),
disease characteristics, disease duration (1 to 28 years) and ethnicity (Whites, South Asians).
Eleven themes emerged as important to the patients: prognosis and course of disease; body
image; effects of treatment; emotional difficulties; inability to plan due to disease unpredict-
ability; fatigue; pain; career prospects and loss of income; memory loss/concentration; reliance
on others to assist with everyday tasks; and pregnancy issues. Most patients reported a neg-
ative impact of SLE on their lives although a few patients found positive aspects to having
SLE. The findings of this study identified themes important to patients with SLE and these
themes will inform clinicians on the patients’ perspective of having SLE. Lupus (2010) 0, 1–8.
Key words: patients’ perspective; qualitative; systemic lupus erythematosus
Background
Systemic lupus erythematosus (SLE) is a complex,
chronic, multi-system autoimmune disease which
varies in prevalence and incidence depending on
ethnicity.1,2 In the UK, it is more common in
Afro-Caribbeans, Chinese and Asian populations
compared with Whites.2 The disease varies in man-
ifestations and severity between individuals. Renal
or central nervous system involvement can be life-
threatening and skin or joint involvement can result
in disﬁgurement.3,4 Non-organ-speciﬁc symptoms
such as fevers, fatigue, weight loss and lymphade-
nopathy are also prevalent and can be debilitating.
The clinical course of SLE is unpredictable and is
characterized by remissions and relapses. The
severity is also variable with some individuals
being mildly aﬀected and leading fairly normal
lives, whilst some patients have frequent and life-
threatening ﬂares requiring repeated and prolonged
critical care. Although several drugs can modify the
disease suﬃciently for the patient’s symptoms to be
tolerable or vital organs to be protected from per-
manent damage, none are curative. Treatment of
severe disease involves the use of potent, and poten-
tially toxic, immune-suppressive regimens with side
eﬀects being common and potentially as problem-
atic as the disease itself.
The severity of SLE is assessed by measuring
three components: the activity of the disease, the
amount of damage to the organs as a result of the
disease or treatment, and the impact of the disease
and/or treatment on the quality of life.5 Disease
activity and damage are assessed by the clinician,
whereas quality of life encapsulates the patient’s
perspective. Measuring these components is impor-
tant because disease activity is reversible with treat-
ment and controlling disease activity will in turn
reduce damage and this is important as the
amount of damage is inversely related to survival.
Assessment of health-related quality of life
(HRQoL) alongside clinical measures of disease
activity and damage provides a more comprehen-
sive and holistic picture of the patient and their
disease. For example, disease activity indices may
improve, but the patient may potentially feel worse
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due to the side eﬀects of the treatment. Therefore, it
is important to assess HRQoL as it provides
another dimension of treatment response, other
than disease activity and damage.6 In addition,
the survival of patients with SLE has signiﬁcantly
improved in the last 60 years.7 This means that
HRQoL is becoming increasingly important as an
outcome measure for SLE. Although a single deﬁ-
nition remains elusive, most investigators of
HRQoL agree that it is a multi-dimensional con-
cept and relates to the impact of the disease and its
treatment ‘on an individual’s ability to function
and his or her perceived well-being in physical,
mental and social domains of life’.8
As part of the initial development of a SLE spe-
ciﬁc HRQoL measure, we undertook a piece of
qualitative work to explore, describe and clarify
the patients’ perspective of how SLE has impacted
on their lives. This will be described in detail in this
paper.
Methods
The study employed an interpretative phenomeno-
logical approach,9,10 a qualitative methodology for
obtaining an individual’s subjective experiences, in
this case ‘of having SLE’. In order to obtain the
views and experiences of people who have SLE,
semi-structured interviews were chosen as the best
approach to explore the phenomenon of the ‘lived
experience of SLE’.11 This should provide insight
into the meaning of living with SLE from the
patients’ perspective.
Following Local Research Ethics Committee
approval, participants were recruited from the
rheumatology service at Blackburn Royal
Inﬁrmary. Patients were invited to take part if
they were 18 years or older and fulﬁlled the ACR
criteria for SLE.12,13 Patients with major unstable
psychiatric disease were excluded. Purposive
sampling was used to recruit patients, with the
emphasis placed on trying to obtain as broad a
range of the individual patients’ lived experiences
of SLE across as wide a range of age, disease
characteristics, disease duration and ethnicity as
possible. Thirty patients meeting the inclusion
criteria were provided with written information
about the planned study and all of them agreed
to take part.
Interview questions
The questions asked in the interviews were
informed through consideration of the literature
exploring well-being and HRQoL, both general
and in relation to SLE, the psychosocial and phys-
iological aspects of SLE, discussions with multidis-
ciplinary staﬀ providing care for patients with SLE
and examination of existing generic and rheumatol-
ogy speciﬁc HRQoL questionnaires. The semi-
structured interview schedule is illustrated in
Appendix 1.
Data collection
Participants were given the choice to have the inter-
view conducted at their home or in the hospital.
Fifteen of the sample chose to be interviewed in
hospital and the other 15 were interviewed in
their own homes. Following an introduction by
the researcher (KM), further clariﬁcation of the
purpose of the study was given and an opportunity
was provided for the participants to ask questions.
Informal conversation took place before the inter-
view in order to put the participants at their ease.
Formal written consent was obtained and they were
reassured that they could stop the interview at any
time and withdraw from the study if they so wished.
The patients were asked how they felt having SLE
had impacted on their lives. Consistent with the
interpretative phenomenological approach, free
conversation was encouraged and the semi-struc-
tured interview schedule was only employed as a
guide.14,15 This allowed the patient ﬂexibility to
follow their own concerns and also for the
researcher to probe areas of interest.10 A counsel-
ling service was made available if there was need for
support with emotional or distressing aspects of the
interview (although this was not required by any of
the participants). An interpreter was present when
the patient did not have a good command of the
English language and four of the eight Asian
patients utilized this facility.
The participants’ gender, age and duration of
disease were documented. The interviews were
recorded and ﬁeld notes were also taken in order
to facilitate the interpretative process16 and reduce
recall bias.17 In general, interviews lasted between
60 and 90 minutes.
Data analysis
Analysis was iterative in approach and it was
observed that no new themes emerged from
patients following interviews with the ﬁrst 25 par-
ticipants. The remaining ﬁve were interviewed in
order to check that, indeed, there were no new
themes. Interpretative phenomenological analysis
(IPA) was used to analyse the data.
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Each interview was transcribed as soon as possi-
ble after its completion. This entire process was
conducted manually. The interview transcripts
were analysed thematically and a rigorous method
of working through the interview transcripts was
devised17 as were methods of coding and categoriz-
ing the data. Validity checks were maintained
throughout the analysis by checking and recheck-
ing the emerging categories. The transcripts were
read and re-read and aspects relating to the
impact of SLE on the patients’ lives were identiﬁed
and extracted. These were organized (separated or
clustered together) into groups and from these the
themes emerged. The emerging themes were veriﬁed
by continual reference to the transcripts. The
themes were later placed into larger families.
Furthermore, the transcripts were independently
analysed by a second researcher to ensure that com-
parable interpretations were being made. Where
discrepancies existed, these were discussed until a
consensus was reached.
Below is an example of the coding of the follow-
ing piece of text to illustrate the methodology.
(Key: Underlined – fatigue, Bold – emotional func-
tioning, Bold and underlined – physical
functioning.)
I think I feel frustrated, sometimes when my joints
ﬂare up I can’t even do the housework and the tired-
ness, I do sometimes start things and have to stop –
have to give up and then I get really frustrated. I get
angry. I get really angry and I probably, well I know
that I do take it out on my husband. I think he thinks
I’ve had a personality change sometimes like some
kind of implant – you know. I can have mood swings
because I am so frustrated and don’t know how to
get out of the situation. I feel angry that I have got
this disease I mean when I was ﬁrst diagnosed I
thought, I thought why, why have I got this disease.
I still think I haven’t come to terms with it fully but it
is just like my whole world has been turned upside
down.
It is also apparent in this piece of text that several
themes are referred to with some overlap as for
example the frustration is an emotional response
to being unable to complete a physical task due to
fatigue. It is also important that the text is analysed
in context as it could be said that starting things and
having to give up before completion could also refer
to physical function but in this context it referred to
a lack of stamina under a cluster related to fatigue.
The primary and higher level themes identiﬁed in
the interview transcripts informed the development
of items for the HRQoL questionnaire.
Exemplars from the transcripts were identiﬁed to
support each of the themes and this allows the
reader to visualize the person in the situation as
well as to further interpret and understand the
text and the true ‘authentic’ nature of the experi-
ences revealed. The provision of these examples
also supports the trustworthiness of the ﬁndings.18
Results
Patient demographics and the range of clinical
manifestations are given in Table 1. A number of
themes/concerns were expressed and these are
described in detail below. For each theme, an exem-
plar from patients has been included in Appendix 2
and they give a ﬂavour of the patients’ perceptions
of living with lupus and how it impacted on
their lives.
Themes/concerns
Prognosis and course of disease
Almost all patients were concerned about whether
other organ systems would be aﬀected in the future
and whether new or diﬀerent symptoms were a pro-
gression of their lupus. Many expressed the concern
that this disease could be hereditary and would be
passed on to their oﬀspring.
Body image
This related mainly to the cutaneous features of the
disease (presence of a rash, scarring as a result of
discoid lupus or alopecia) and also the weight gain
as a result of treatment with steroids. The most
frequently reported distressing aspect for the
patients was steroid related weight gain.
Table 1 Patient characteristics and clinical manifestations
Age in years – mean (SD) 48.9 (13)
Disease duration in years – mean (SD) 9.2 (8.4)
Education in years – mean (SD) 12.7 (4.5)
Gender 30 females, 0 males
Ethnicity 22 Whites
8 South Asians
Clinical features – number (%)
Mucocutaneous 16 (53)
Musculoskeletal 23 (77)
Serositis 8 (27)
Neurological disease 5 (17)
Renal disease 5 (17)
Haematological disease 12 (40)
Positive anti-nuclear antibodies 28 (93)
Positive anti-dsDNA, Sm or phospholipid 26 (87)
antibodies
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Effects of treatment
Patients were concerned mainly with the long-term
eﬀects of taking potentially toxic treatments but
also the visible side eﬀects. One patient had devel-
oped osteoporosis and three had developed cata-
racts due to steroid treatment. One patient was
avoiding the gym in case she developed muscles –
having the widely held misunderstanding that she
was taking anabolic steroids
Emotional difficulties
Two-thirds of the patients reported that they expe-
rienced emotional diﬃculties. A broad range of
emotions was expressed, e.g. anger, frustration,
resentment, anxiety and poor self-esteem. One of
the most widely reported emotions was frustration
for a variety of reasons. One was other people’s
perception of them when they were unable to func-
tion as there was nothing observably wrong with
them and that as they looked well they were ‘swing-
ing the lead‘. One patient was relieved to be hospi-
talized for an intravenous infusion as it was
demonstrable evidence that she was ill.
Inability to plan holidays/social events due to the
unpredictability of the disease
The patients frequently reported being unable to
plan ahead to attend events. Some dealt with this
by not committing themselves to anything and
refusing invitations but were also concerned that
they were isolating themselves and in the future
would not be invited.
Fatigue
Even in the absence of aches and pains patients
reported feeling exhausted, feeling like staying in
bed and having to force themselves to get out of
bed. Several patients reported that fatigue pre-
vented them from doing things that they enjoyed.
Pain
The presence of pain prevented participants from
doing the housework, gardening and even occa-
sionally attending to personal hygiene.
Career prospects and loss of income
Some patients who were working found it diﬃcult
to continue in their job because of not only the
symptoms but also the unpredictability of the dis-
ease. Consequently, they had to give up their work
with the resultant loss of income, which in turn had
a negative emotional impact with increased worry-
ing. Younger patients felt that the disease was a
hindrance to their career progression mainly
because they were unsure how their disease would
be in the future and whether they could take on
more responsibility. However, some participants
reported feeling relieved to give up their work
because they felt they were underperforming and
a burden on their colleagues, or they hated their
job and it provided a useful excuse to leave.
Those who continued in employment often
reported it as a struggle as they had repeated
absences due to the relapsing nature of the disease.
Memory loss/concentration
Some had developed strategies for coping such as
the generation of lists. One patient found it parti-
cularly distressing and gave the description cited in
Appendix 2.
Reliance on others to assist with everyday tasks
Participants reported that their partners/children
now do most of the housework (vacuuming, iron-
ing, shopping, preparing meals). One Asian lady
who relied heavily on her daughter was concerned
that this would inﬂuence her daughter’s marital
prospects. Many were concerned about this appar-
ent loss of independence and felt guilty that they
were a burden as they were unable to perform what
they perceived to be their role. Two patients
expressed distress that the disease was placing a
burden on their physical relationships with their
partners. And one young girl was concerned that
she may not ﬁnd a partner who would understand
the limitations the disease placed on her.
Pregnancy
Two patients reported that the disease had limited
their family size, in one case preventing her from
having any children. The other patients were con-
cerned for their future but it was not currently an
issue for them. Other patients had been diagnosed
after they had completed their families and it there-
fore had not impacted on their lives in this respect.
Positive aspects
It is important to note that some patients reported a
positive impact of having SLE. One patient reported
that she was relieved to have a good excuse to
give up a job that she didn’t enjoy. A few patients
also said that they had developed good quality rela-
tionships with friends through having SLE.
Discussion
In this study we sought to identify the impact
of living with SLE directly from patients, with the
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ultimate aim of developing a SLE disease-speciﬁc
HRQoL questionnaire. The ﬁndings illustrate the
predominantly negative way that having SLE
impacts on patient-perceived HRQoL.
Much of the qualitative literature on living with
SLE outlined similar negative concepts.19–21
Wiginton19 interviewed 20 female patients with
lupus to explore the cognitive maps of living with
lupus and reported similar themes to those found in
our study. However, the concept of feelings of inad-
equacy as mother/caretaker was only reported by
those in the younger group (age 27–43 years) whilst
those in older group (age 44–60 years) reported the
concept unpredictability/uncertainty more often
than the younger group. In our study the aim was
to establish those areas that this disease impacted
on patients’ lives in general so no attempt was
sought to identify themes that were more
common to diﬀerent age groups. Goodman
et al.20 used semi-structured interviews and inter-
pretative phenomenological analysis to explore
the content of the illness representations held by
36 female patients with SLE. The majority reported
enormous physical, social and emotional conse-
quences, most of them negative. However, ﬁve par-
ticipants reported some positive consequences to
having SLE. Similarly, in our study, a small
number of patients reported that whilst SLE was
mainly detrimental to their quality of life, there
were some positive aspects such as a genuine
excuse to give up a job and making good quality
relationships. These positive aspects may well tem-
perate the negative impact of having SLE. In the
study by Archenholtz et al.,21 50 SLE and 50 rheu-
matoid arthritis (RA) patients were interviewed by
telephone with a view to establishing content valid-
ity of a Swedish version of the Quality of Life Scale
(QOLS). In both groups the domains identiﬁed
were similar although some domains (e.g. fatigue)
were more emphasized by SLE patients. These
patients also felt a lack of control over their
bodies and a lack of understanding of the disease
by doctors and by people in general. Thus having
SLE appears to have a greater negative impact on
the patients than having RA.
Understanding the impact of SLE on the
patients’ lives is essential as it may allow clinicians
to particularly address these concerns, and in order
to do that it is necessary to have tools that can
measure this impact. This is particularly important
as survival of SLE patients has improved dramati-
cally compared with 50 years ago.7 HRQoL mea-
sures facilitate such assessments. The most widely
used questionnaire to assess HRQoL is the generic
measure, the Medical Outcome Survey Short
Form-36 (SF-36). Its use has provided valuable
insight on the impact of SLE and made it possible
to compare HRQoL in SLE patients with that of
other diseases. The SF-36 is valid in SLE patients
but some domains that are important to SLE
patients are notably absent such as sleep distur-
bances, intimate relationship and body image.22–24
This deﬁciency supported the need to develop a
disease-speciﬁc HRQoL measure for SLE.
To ensure that the domains that are important to
patients are included in the questionnaire, patients
should be the source of items for these measures
thus assuring the instrument’s acceptability and rel-
evance to them.25 Over the past six years, apart
from the LupusQoL measure,26 which we devel-
oped and validated using the data from this quali-
tative study, three other SLE-speciﬁc HRQoLs
have been developed and validated world-wide:
the SLE symptom checklist (SSC) in the
Netherlands,27 the SLEQOL in Singapore,28 and
the L-QoL in the UK.29 Like the LupusQoL, the
items for the SSC and the L-QoL were derived from
patient interviews whereas the items for the
SLEQOL were derived from Wiginton’s concepts19
and veriﬁed by SLE patients. The SSC consisted of
a list of symptoms and how burdensome these
symptoms were to the patients and thus was not
strictly a multi-dimensional HRQoL measure. The
L-QoL was a needs-based questionnaire and the
main issues derived from the interviews of patients
were two-fold: one common to many chronic rheu-
matological diseases (reduced energy, tiredness,
lack of motivation, constant pain) and the other
characterized by SLE (concerns about image por-
trayed to others, impact on personal relationships
and concerns about the future). Many ‘needs’ were
frustrated by SLE and included freedom from pain,
adequate reserves of energy, conﬁdence, indepen-
dence, control over one’s life, attractiveness,
giving and receiving love and belonging.
Our study demonstrates agreement with and con-
ﬁrms much of what has been in the qualitative and
quantitative literature. The fact that the data from
our study arrives at converging conclusions with
both quantitative and qualitative data from other
SLE populations serves as amethod of triangulation
and in conjunction with the previously described
procedures ensures the validity of the study.
In summary, despite the improvement in survival,
SLE and its treatment have a signiﬁcant impact on
the lives of SLE patients. These patients have poorer
HRQoL as compared with the general population.30
Major organ involvement commonly has a marked
deleterious eﬀect on physical, mental and
social health and this has been conﬁrmed by this
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qualitative study. Moreover, fatigue is almost a uni-
versal feature in SLE and can be so disabling that it is
diﬃcult to fulﬁl social events and/or everyday activ-
ities.30,31 The study also shows that this can impact
on the patient’s ability to function as a mother, wife,
friend or co-worker, with possible ﬁnancial implica-
tions, and may lead to marital or relationship prob-
lems.32 Changes in appearance due to side eﬀects
from treatment (such as Cushingoid features and
weight gain) and involvement of skin and joints
aﬀect the patients’ perception of body image and sex-
uality, which can have an impact on emotional
health.4 Apart from that, issues relating to choice
of contraception, potential eﬀect of medication on
fertility/pregnancy, the unpredictable nature of the
disease and potential heritability of the disease may
lead to anxiety and worry. It is essential that as clini-
cians we understand the signiﬁcant impact of SLE
on the patients’ lives and in doing so may be able
to initiate remedial management to address these
issues.
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Appendix 1 Semi-structured interviews
Appendix 2 One Exampler from each of the 11 themes
Prognosis and course of disease
‘‘My concern is for the future and having kids worry me especially with miscarriages and that. I worry if I am having a really bad couple of weeks at work and
under a lot of pressure if that will affect it’’
Body Image
‘‘When it came up I felt a bit embarrassed. People asking you what’s that mark on your face but now I say that is just part of my illness and shut them up because
I don’t like explaining too much. I have come to terms with it now and then, even like hair loss, they say oh gosh, you’re losing your hair – in the beginning I used
to feel really embarrassed but now I know its part of my lupus. But it was when it started I felt really, really bad for someone to tell me. At first it bothered me it
really did but I know what it is now because then I didn’t know as much but while I was reading it said that hair loss is one of the symptoms. Now if somebody
says I still feel a bit but not as strong as I did before I mean I used to come home and cry – gosh I’m losing my hair and people are noticing it. Losing my hair
bothered me more than the marks on my face. ’’
Effects of treatment
‘‘I think the side effect of medication should be explained in more detail – obviously one being steroids because I put two stone on. I got a leaflet to take home and
weight was mentioned but played down I think and I am sure I am not by myself in saying this’’.
Emotional difficulties
‘‘It makes me angry because you look well they think oh there is nothing wrong with her and that attitude really gets me. When they look at you, they think look at
you, you are walking, talking, healthy, all medication. If we didn’t have that we would be nowhere near where we are now. It is so difficult to make them
understand.’’
Inability to plan/unpredictability of the disease
‘‘I used to be a member of the gym and used to pay a yearly subscription and then I kept finding that I’d go for a while and then I couldn’t go for four months – I’d
reach a point where I would feel well and then it flares again ’’
Fatigue
‘‘When you have not many aches and pains, you still have exhaustion. If you are the type of person like me when you wake up in the morning, I don’t feel like I
have had a good night’s sleep even when I have but if I gave in to it, I would lay there in bed all day I think’’
Pain
‘‘Joint pain stops me walking very far I used to go to the gym – I don’t now. I used to swim quite a lot, I don’t do that now. My knees sometimes give way. My leg
gives way so I am a bit frightened of actually coming out of the changing rooms, you know on to the side of the pool and the results of that, of not doing those
things have made me gain so much weight and I have put so much on I feel like it has hampered my joints and it is like a vicious circle that I don’t know how to
break’’.
Career prospects and loss of income
‘‘I think what really concerns me is how it is going to affect my work. I have come to that point now where, see again, it is people at work not really being aware
trying to encourage me now to go for the deputy headship and the deputy headship is coming up at my school this September and people can’t understand why I
don’t want to apply. But really I just don’t want to commit myself to that much – I don’t feel well enough and I don’t feel I could take it and then I have a flare
and be off for however long. Or even two years down the line, not be well and not be able to put 100% into it and I am a bit of a workaholic if I am going to do
something, I am going to do it well. And I think part of me feels that I would like to work part time. I think I would feel more well and that’s something we have
discussed recently but I mean there are financial considerations but maybe twelve months from September so that we have time to plan it. I mean I don’t want to
give up working completely but 1 do feel that if l didn’t have lupus 1 would have gone for promotion years ago’’.
(continued)
Are there any positive aspects – that make life more enjoyable?
What are your concerns related to having lupus?
Prognosis
Course of disease
Sunbathing/sunny holidays
Pregnancy
Effects of treatment
Effects on family life
Body image
Difficulty in concentrating/memory
Socializing/worry about infection
Loss of income
What makes life less enjoyable/difficulties?
Physical aspects
Emotional
How does SLE make you feel? – angry, bitter, resentful, irritable, so fed up
all the time that nothing can cheer you up, anxious, frustrated, other
people’s perceptions of your illness
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Appendix 2 Continued
Prognosis and course of disease
Memory loss and loss of concentration
‘‘lack of organisation, it’s like your mind’s in fifth gear and your body can’t get out of first’’
Reliance on others to assist with everyday tasks
‘‘. . .and essentially its finding somebody who is willing to put up with me like I mean my boyfriend is very supportive. He understands totally about it and I know
that I can talk about it and he will be there for me. But it is finding a partner who can take it day by day and understand about your holidays and stuff like that.
And understand that if we had kids in the future I wouldn’t have the full energy that I should have as a parent’’
Pregnancy
‘‘. . .but it is only now that it has stopped me from doing something and that was the baby. Em well because I was on azathioprine and I got pregnant accidentally
and I wanted one for the last 12 years but decided to have a termination because of the treatment. And when I asked the doctor at clinic if l would ever be able to
come off the treatment and she said it was unlikely so the prospect of not being able to have the extended family’’ – (participant becomes tearful at this point)
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